CoreAge Rx Review: Following the Care Path From Intake to Delivery

An online prescription service is more than a checkout page: someone must review the medical history, decide whether to prescribe, prepare the medication, deliver it and respond afterward. CoreAge Rx describes a pathway connecting those steps for compounded semaglutide and tirzepatide. The central question is not simply how quickly someone can enroll, but which organization becomes responsible at each handoff—and what happens when approval, payment or delivery does not go as expected.

Public pages consulted October 19, 2026 describe an American telehealth platform with confidential online intake, independent medical entities and partner pharmacies. They also contain consequential disagreements about pharmacy choice, automatic renewals, payment timing and refunds. This documentary review follows the service from enrollment through ongoing support, distinguishing the company’s advertised arrangements from independently established clinical evidence. No clinician or pharmacy credentials were independently verified, and the advertised experience was not tested through a purchase.

At a glance

Who provides medical care: CoreAge Rx identifies itself as the technology and administrative coordinator; three independently owned professional entities handle evaluations, treatment planning and prescribing.
Sources: [11]
Advertised starting prices: The homepage advertises compounded semaglutide from $79 per month and compounded tirzepatide from $129 per month, with supplies and shipping included; another homepage block says GLP-1 treatment starts at $99 per month.
Sources: [11]
Access restrictions: The FAQ limits service to adults 18 and older in the United States, with availability varying by state, therapy and medication.
Sources: [7]
Pharmacy choice is unresolved: The FAQ requires affiliated pharmacies, while the terms allow a request to use a chosen pharmacy before completing an order.
Sources: [7] [12]
Refund promises conflict: The FAQ promises a full refund if prescribing is not approved; the refund policy allows an applicable nonrefundable consultation fee of $50–$100 and other refund limits.
Sources: [7] [5]

Start by identifying the organization responsible for care

CoreAge Rx’s help center describes a U.S. telemedicine service specializing in prescribing and providing compounded semaglutide and tirzepatide. Its legal footer makes a more precise distinction: DSO Fine Shrimp, doing business as CoreAgeRx, supplies technology and administrative coordination. It says that company does not practice medicine, employ healthcare providers or participate in clinical decisions. The refund policy identifies DSO Fine Shrimp LLC and gives a contact address at 1309 Coffeen Avenue, Suite 1200, Sheridan, Wyoming 82801.

The medical work is assigned exclusively to M & D Integrations Inc, doing business as MD Integrations; MDI Medical Group P.C.; and MD Integrations & Wellness Provider Group P.A. The footer describes those professional entities as independently owned and operated. That division matters when requesting records or clarifying who made a prescribing decision. Our guide to clinicians and telehealth platforms explains the distinction between an administrative brand and the organization delivering medical care.

The product page says prescriptions are overseen by fully licensed and insured physicians, while other homepage language refers to U.S.-licensed clinicians. These are provider representations, not independent credential checks. Before paying, a prospective patient can ask which professional entity will provide the consultation and how the treating clinician will be identified. The public structure is reasonably explicit about corporate roles, but those disclosures do not establish who will personally handle a particular patient’s assessment.

The documented care handoffs and the questions still worth asking
Stage	Documented responsibility	Question to resolve
Enrollment	CoreAge Rx provides the platform and administration.	Who handles an incomplete intake or payment dispute?
Medical review	Independent professional entities evaluate and prescribe.	Which entity and clinician will review my case?
Pharmacy fulfillment	A partner pharmacy is selected by therapy and medication.	What is the pharmacy’s name, and can I choose another?
Delivery	The pharmacy ships; CoreAge Rx coordinates applicable transit remedies.	Who handles temperature concerns or a missing package?
Ongoing care	Plans advertise provider access; medical questions go through the portal.	What response time and scheduled follow-up are included?

Sources: [14] [11] [5] [13]

Intake comes before a prescribing decision—not guaranteed treatment

The advertised starting point is a confidential online health questionnaire, followed by review of the answers by a doctor. The FAQ estimates feedback within approximately 24 hours, but says certain states require a video consultation or live chat. The help center separately says a telephone consultation is unnecessary unless requested. Together, these descriptions support a primarily online process, not a promise that every applicant can complete assessment without a live interaction.

Enrollment is limited to people 18 or older, and service is offered only within the United States. State restrictions depend on the therapy and medication and are disclosed during intake. The consulted documentation does not provide an exhaustive state-by-state list or establish specific BMI thresholds, qualifying conditions or mandatory testing for every offering. Age and location therefore provide only an initial screen; they are not confirmation that a prescription will be appropriate or available. CoreAge Rx’s safety page says not to use compounded semaglutide with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a previous serious hypersensitivity or allergic reaction to semaglutide or any formulation ingredient, or during pregnancy or when planning pregnancy. These are semaglutide-specific restrictions stated by the provider, not a complete eligibility assessment.

Depending on treatment, the policy allows requests for medical history, current medications, photo identification, patient photographs, laboratory results, medical records, primary-care documentation and answers to additional questions. These requests can extend the pathway beyond the first questionnaire. Preparing relevant information using a first-consultation checklist may help organize the discussion, but it cannot determine eligibility. NIDDK advises discussing medicines, supplements, allergies and pregnancy plans with the clinician rather than treating enrollment as a purchasing decision alone.

Sources: [13] [7] [14] [5] [2] [10]

Confirm the formulation, not just the ingredient name

CoreAge Rx markets compounded semaglutide and compounded tirzepatide, rather than presenting these offerings as FDA-approved branded products. Its semaglutide safety page describes subcutaneous injection. The FAQ says compounded tirzepatide is typically formulated with B-12; someone seeking a formulation without B-12 can note that preference during intake and discuss it with the provider. That is a discussion option, not a guarantee that a particular alternative will be prescribed or supplied.

The catalog also includes “Semaglutide Microdosing Therapy” starting at $79 per month and “Tirzepatide Microdosing Therapy” starting at $129 per month. The latter is marketed as a customized GLP-1/GIP protocol for metabolic support. These commercial labels do not establish clinical effectiveness for those specific preparations or protocols. Separately, the company’s GLP-1 Support product is expressly described as a dietary supplement, not a prescription medication; it should not be confused with the prescription offerings.

FDA says compounded preparations are not FDA approved and do not receive its premarket review for safety, effectiveness and quality. Nonapproval alone does not demonstrate clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Research on approved products also does not establish outcomes for CoreAge Rx’s compounded formulations, vitamin blends or microdosing offerings. The prescribing discussion should establish the exact product and its rationale.

Sources: [8] [9] [7] [10] [6] [1] [3] [4]

The first payment has unresolved conditions

The homepage advertises compounded semaglutide from $79 per month and compounded tirzepatide from $129 per month, saying every dose costs the same and supplies and shipping are included. Another homepage block advertises the two ingredients collectively from $99 per month. These are starting prices, not individualized quotations. The consulted pages do not establish the supply quantity, purchasing conditions or final checkout total needed to obtain each minimum, and a monthly advertisement does not itself establish a minimum commitment.

The semaglutide page advertises no membership fees and no long-term contracts. The help center additionally promises that the price becomes permanently fixed after purchase and will not rise with dose increases. Those are commercial commitments that should be confirmed for the selected order. More fundamentally, the FAQ gives two payment timelines: it explains charging before medical review to secure pricing and a pharmacy-queue position, yet elsewhere says medication is billed when shipped. The documentation does not reconcile those statements.

CoreAge Rx says it does not accept insurance. Its terms also say the services are not insurance and that purchasers agree not to submit telemedicine claims to Medicare or other federal, state or private payers. The refund policy mentions Klarna, Affirm and other financing providers, but the consulted material does not establish their financing terms or universal availability. Ask for the actual charge schedule, selected plan, consultation fee and payment obligations before relying on the headline monthly amount.

Sources: [11] [13] [14] [7] [12] [5]

The pharmacy handoff needs written clarification

The FAQ says a prescription is filled by a partner pharmacy chosen according to the therapy and medication, and directs patients to support to learn which pharmacy will handle it. It does not identify a dispensing pharmacy for a particular applicant. That leaves an important handoff unresolved before purchase: the platform’s brand is not the pharmacy’s identity. The company’s statements about its pharmacy network should not be read as independent verification of any pharmacy’s licensing or operations.

There is also a direct disagreement about choice. The FAQ answers the local-pharmacy question with “No, not at the moment” and says prescriptions must use the affiliated network. The terms, however, say patients may direct a prescription to a pharmacy of their choosing by emailing support@coreagerx.com before completing the order. Neither statement explains how the alternative would affect the advertised package price, formulation or included shipping. A written answer is more useful than assuming either page settles the matter.

Our pharmacy-handoff questions can help structure that exchange: identify the dispensing pharmacy, confirm the intended formulation, and establish whom to contact about preparation or fulfillment. The distinction is practical because approval and transmission to the pharmacy are also refund milestones under CoreAge Rx’s policy. Knowing that an order is “with the pharmacy” should trigger a clear status explanation—not an assumption that the medication has already been prepared, dispatched or delivered.

Sources: [7] [12] [5]

Separate medical review, order completion and arrival

The approximate 24-hour feedback estimate concerns medical review, not delivery. The policy says orders are typically completed in approximately five to seven business days when all required information is submitted promptly, while acknowledging variable processing times. It separately estimates arrival approximately two to three business days after the pharmacy ships. These are different stages, and neither statement establishes a guaranteed purchase-to-door timeline. Documentation requests, approval and pharmacy preparation occur before shipment.

Standard prescription shipping is included unless checkout discloses otherwise. The policy permits USPS, UPS, FedEx or another designated carrier, and says tracking is emailed after shipment. The FAQ describes no-contact delivery without a required signature. For loss or transit damage, patients should contact the Patient Care Team promptly; CoreAge Rx says it will review the circumstances and work with the pharmacy or carrier on replacement or reshipment when applicable. That wording is conditional, not an unconditional replacement promise.

The consulted pages do not precisely document refrigerated packaging, temperature monitoring or procedures for temperature excursions. This is a material gap for an injectable delivery pathway, not evidence that a particular shipment will be mishandled. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. Our guide to warm injectable deliveries explains that advice; a tracking confirmation alone cannot resolve a product-condition concern.

Sources: [7] [5] [1]

Ongoing access is advertised, but the clinical schedule is unclear

The semaglutide page says every plan includes ongoing provider access and a community organized around patient goals. It does not establish a scheduled follow-up interval, refill-review frequency or continuing clinical response deadline. A heading advertises “24/7 Provider Support,” but the accompanying explanation refers to the customer-support team being available around the clock. That wording does not document a physician—or another treating clinician—being continuously available for medical decisions.

The Spanish-language help center gives concrete contact routes: call or text (307) 405-1638, use the portal’s “Talk to the Doctor” function for medical questions, and email support@coreagerx.com for billing or technical issues. A Spanish help center does not itself confirm Spanish-language clinical consultations. Patients should ask which channel reaches the treating team, how quickly clinical messages are answered, and whether follow-up consists of scheduled encounters, asynchronous messages or another arrangement.

This distinction matters because NIDDK describes follow-up as assessment of response and tolerability, not simply continuation of payments. FDA has also received reports of errors measuring or administering compounded medication, including some associated with hospitalization. That general warning is not a CoreAge Rx-specific event rate. Instructions should be clarified with the prescriber or pharmacist rather than reconstructed from advertising, community discussion or this review. The public promise of access is useful, but its operating details remain important.

Sources: [13] [14] [2] [1]

Stopping payments and reversing an order are different processes

The help center describes a choice between a one-time purchase and an optional subscription, with automatic renewal only for the latter. The FAQ instead says there are no automatic rebills, while elsewhere discussing a refill notice and card charge. The policy permits subscription cancellation through the patient account or Patient Care Team to prevent future renewal charges. Confirm the selected arrangement and cancel before the relevant renewal is processed; stopping future billing does not automatically reverse an existing order.

For an order cancellation, the policy requires that the prescription has not been approved, has not been transmitted to the pharmacy and has not become nonrefundable under its 30-day rule. Once approval and transmission have both occurred, it declares prescription sales final even if medication has not shipped. Separately, orders become nonrefundable 30 calendar days after purchase, even if incomplete or unshipped, except where applicable law requires otherwise. Delayed documentation can therefore have financial consequences before delivery.

The FAQ’s promise of an automatic 100% refund when prescribing is declined conflicts with the policy’s narrower return of the refundable medication or treatment portion, retaining an applicable $50–$100 consultation fee. Approved refunds are generally processed within five to ten business days; banks may take additional time. Financing refunds are submitted through the financing provider. Request written clarification of these differences before purchase, especially the consultation charge, the documentation deadline and the point at which the order becomes final.

Sources: [14] [7] [5]

Questions & answers

Can I use CoreAge Rx from any U.S. state?

Not necessarily. CoreAge Rx says it serves adults 18 and older in the United States, but state availability depends on the therapy and medication. Restrictions are confirmed during intake. The consulted pages do not provide a complete state list, so confirm availability for the specific offering before treating the advertised price as an accessible option.

Sources: [7]

Will I have a video visit before receiving medication?

The process starts with an online questionnaire, and the FAQ estimates medical feedback in approximately 24 hours. It says certain states require video consultation or live chat. The help center says a telephone consultation is not required unless requested. These descriptions do not guarantee that your assessment will be entirely asynchronous or completed within one day.

Sources: [13] [7] [14]

Can I request tirzepatide without B-12?

The FAQ says compounded tirzepatide is typically formulated with B-12. It invites patients who prefer a version without B-12 to record that preference during medical intake and discuss it directly with the provider. It does not guarantee approval or availability of that formulation. Ask what exact preparation would be prescribed and which pharmacy would supply it.

Sources: [7]

Can CoreAge Rx send the prescription to my local pharmacy?

The public documentation gives conflicting answers. The FAQ requires its affiliated network, while the terms allow a pharmacy-choice request emailed to support@coreagerx.com before the order is completed. Obtain written confirmation before paying, including whether the chosen pharmacy can fulfill the prescription and whether using it changes the advertised price or shipping arrangement.

Sources: [7] [12]

Do I receive all my money back if the clinician declines treatment?

That is unresolved in the public terms. The FAQ promises an automatic full refund, but the policy says an applicable $50–$100 consultation fee is nonrefundable and returns only the refundable treatment or medication portion. Ask which rule applies to your order before payment. Processing an approved refund within five to ten business days does not guarantee bank receipt within that period.

Sources: [7] [5]

Does the 24/7 support promise mean a clinician is always available?

The consulted wording does not establish that. Although the heading says “24/7 Provider Support,” its explanation describes around-the-clock customer support. Medical questions are directed to the portal’s doctor-contact function. Ask for the clinical message response time and follow-up schedule; neither is established by a general customer-service availability claim.

Sources: [13] [14]

Our assessment

CoreAge Rx documents a recognizable telehealth pathway: online intake, medical decisions by independent professional entities, pharmacy fulfillment and home delivery, with advertised ongoing provider access. Its contact routes and separation of clinical from administrative responsibilities are useful. The principal weakness is inconsistent documentation at consequential handoffs—not merely missing promotional detail. Pharmacy choice, charge timing, renewal arrangements and the refund for declined treatment all require written clarification. Before purchasing, obtain the exact formulation, pharmacy identity, total charge, consultation fee, renewal selection and clinical follow-up arrangement. The advertised starting prices are worth evaluating, but they do not resolve those responsibilities or establish the quality of care. Compounded treatment also calls for an individual discussion of why an approved product would not meet the patient’s medical needs.

Visit CoreAge Rx’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

CoreAge Rx Review: Following the Care Path From Intake to Delivery

At a glance

01Start by identifying the organization responsible for care

02Intake comes before a prescribing decision—not guaranteed treatment

03Confirm the formulation, not just the ingredient name

04The first payment has unresolved conditions

05The pharmacy handoff needs written clarification

06Separate medical review, order completion and arrival

07Ongoing access is advertised, but the clinical schedule is unclear

08Stopping payments and reversing an order are different processes